The Medical Research Council has reopened curiosity-driven research funding, with a new round of opportunities now available through UK Research and Innovation and several additional calls scheduled to open later this month. The move forms part of a wider funding update that is designed to support discovery science, translational work and the next generation of clinical researchers across the UK.
According to the UKRI announcement, the MRC is unpausing curiosity-driven research funding while also improving how applications are handled. The updated scheme includes applicant-led research, new investigator and partnership grants, alongside several translational and training opportunities that are either already open or due to open soon.
New funding windows span discovery science and training
Among the opportunities listed on the MRC funding page are applicant-led research, new investigator and partnership grants, which opened on 7 April 2026 and do not have a closing date shown on the page. The same list also includes experimental medicine calls, NHS patient flow dementia challenge funding and capacity-building fellowships aimed at strengthening the research workforce.
The next wave of openings includes MRC CoRE round five outline applications on 7 October 2026, experimental medicine stage one and stage two on 8 October 2026, and a series of fellowships and translation schemes later in October and November. These dates place the latest funding activity squarely in the current autumn round of UK research support.
UKRI says it is aiming for faster and clearer grant assessment
UKRI has also said it is modernising grant assessment to speed up decisions and adapt to the growing use of generative AI in research applications. The organisation said its updated approach is intended to improve service for researchers while maintaining confidence in the review process and supporting strong ideas across the system.
The broader changes come as UKRI’s total research and innovation budget is set to rise during the current spending review period, with the organisation saying annual funding will reach almost £10 billion by 2030. In that context, the new MRC funding round signals continued investment in medical research capacity at a time when research organisations are under pressure to deliver both speed and quality in grant decision-making.
A wider push to support UK medical research talent
The latest MRC update is not limited to project grants. It also includes capacity-building and clinical research training opportunities, underlining the council’s emphasis on maintaining a pipeline of investigators who can move from early-stage science into patient-facing research. UKRI’s remit page says the MRC funds work ranging from fundamental discovery science to the development and testing of diagnostics, therapies and preventive measures.
For researchers considering an application, the current round offers a broad spread of options across translational science, experimental medicine and professional development. With several deadlines now in place and more calls due to open through November, the latest announcement gives the UK medical research community a fresh set of funding routes heading into 2027.
Photo source: AI-generated or edited image
